๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Ovarian Neoplasm Epithelial

ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site๐Ÿ“ Liverpool Pierian Biosciences ยท Tests: No intervention A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970NA7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Mind-body resilience training, Music therapy, Propranolol, Etodolac A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites๐Ÿ“ Maumee๐Ÿ“ Portland๐Ÿ“ Fairfax TwoStep Therapeutics, Inc. ยท Tests: TS-104 A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites๐Ÿ“ Newport Beach๐Ÿ“ Stanford๐Ÿ“ Miami Eli Lilly and Company ยท Tests: LY4337713 Registry Platform Ovarian and Endometrial Cancer NCT05129969n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG ยท Tests: Physician's choice according to patient's needs. A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) NCT05601700Phase 319 sites๐Ÿ“ Arezzo๐Ÿ“ Ponderano๐Ÿ“ Belluno Ente Ospedaliero Ospedali Galliera ยท Tests: Letrozole tablets, carboplatin AUC 5 and paclitaxel 175 mg/m2 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC NCT04644289Phase 26 sites๐Ÿ“ Mannheim๐Ÿ“ Mรผnchen๐Ÿ“ Essen AGO Research GmbH ยท Tests: olaparib, durvalumab Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies NCT05457595NA1 site๐Ÿ“ Pavia CNAO National Center of Oncological Hadrontherapy ยท Tests: carbon ion radiation therapy Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco๐Ÿ“ Miami Beach Faeth Therapeutics ยท Tests: Sapanisertib, Serabelisib, Paclitaxel EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ยฑ Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EBNK-001 + IL-15 + Pembrolizumab Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04) NCT05827523Phase 310 sites๐Ÿ“ Sejong๐Ÿ“ Sejong๐Ÿ“ Goyang-si National Cancer Center, Korea ยท Tests: Cisplatin PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI NCT05172310Phase 11 site๐Ÿ“ Stockholm Karolinska University Hospital ยท Tests: 68Ga-FAPI-46, PET/CT AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer NCT07218809Phase 3299 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ La Jolla AstraZeneca ยท Tests: AZD5335, Mirvetuximab Soravtansine (MIRV), Paclitaxel, Pegylated liposomal Doxorubicin (PLD), Topotecan Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer NCT07636200NA2 sites๐Ÿ“ Aurora๐Ÿ“ Boulder University of Colorado, Boulder ยท Tests: Written Exposure-Based Coping Intervention (EASE), Usual Care Control Condition Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer NCT05009082Phase 365 sites๐Ÿ“ Amberg๐Ÿ“ Augsburg๐Ÿ“ Bad Homburg AGO Study Group ยท Tests: Carboplatin, Paclitaxel, Bevacizumab, Niraparib FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer NCT05810701NA5 sites๐Ÿ“ Odense๐Ÿ“ Vejle๐Ÿ“ Roskilde Odense University Hospital ยท Tests: Comprehensive geriatric assessment and individualised physical training Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer NCT07718854Phase 21 site๐Ÿ“ Boston Tufts Medical Center ยท Tests: Sacituzumab tirumotecan, Pembrolizumab A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069Phase 139 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Eli Lilly and Company ยท Tests: LY4052031, Pembrolizumab 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: 68Ga-SorB PET/CT DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Dabrafenib, Trametinib Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer NCT07171528Phase 21 site๐Ÿ“ Goyang-si National Cancer Center, Korea ยท Tests: Secondary Cytoreductive Surgery PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer NCT06549855NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Sintilimab or Pembrolizumab and medroxyprogesterone acetate (MPA)/ megestrol acetate (MA)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy